This episode explores the future of skin biomarkers. Featuring insights from Simon Grant, CEO of Ascilion, and Théo Boyer, Senior Project Coordinator at Indero, the episode examines how dermal interstitial fluid (d-ISF) could revolutionize dermatology. Our guests illuminate the potential of ISF sampling, paving the way for more personalized and innovative approaches to care.
All content for Phase Forward is the property of Podcast Series hosted by Valerie Coveney and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This episode explores the future of skin biomarkers. Featuring insights from Simon Grant, CEO of Ascilion, and Théo Boyer, Senior Project Coordinator at Indero, the episode examines how dermal interstitial fluid (d-ISF) could revolutionize dermatology. Our guests illuminate the potential of ISF sampling, paving the way for more personalized and innovative approaches to care.
Episode 22: Enhancing Clinical Trial Efficiency: 3 Essential CTMS Tips for Sponsors, CROs, and Sites
Phase Forward
11 minutes 18 seconds
10 months ago
Episode 22: Enhancing Clinical Trial Efficiency: 3 Essential CTMS Tips for Sponsors, CROs, and Sites
Robert Taylor, Associate Director of Clinical Operations at Innovaderm, joins us in an episode of Phase Forward. He shares his top 3 tips for improving clinical trial efficiency with CTMS. Learn how centralized data management, process automation, and remote monitoring tools can lower costs and enhance data quality. Perfect for sponsors, CROs, and sites looking to optimize their trials.
Phase Forward
This episode explores the future of skin biomarkers. Featuring insights from Simon Grant, CEO of Ascilion, and Théo Boyer, Senior Project Coordinator at Indero, the episode examines how dermal interstitial fluid (d-ISF) could revolutionize dermatology. Our guests illuminate the potential of ISF sampling, paving the way for more personalized and innovative approaches to care.
